Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Reaching for wellness in schizophrenia.

Kelly DL, Boggs DL, Conley RR.

Psychiatr Clin North Am. 2007 Sep;30(3):453-79. Review.

PMID:
17720032
2.

Schizophrenia and increased risks of cardiovascular disease.

Hennekens CH, Hennekens AR, Hollar D, Casey DE.

Am Heart J. 2005 Dec;150(6):1115-21. Review.

PMID:
16338246
3.

Risk of cardiovascular disease and sudden death in schizophrenia.

Davidson M.

J Clin Psychiatry. 2002;63 Suppl 9:5-11. Review. Erratum in: J Clin Psychiatry 2002 Aug;63(8):744.

4.

Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists.

Goff DC, Cather C, Evins AE, Henderson DC, Freudenreich O, Copeland PM, Bierer M, Duckworth K, Sacks FM.

J Clin Psychiatry. 2005 Feb;66(2):183-94; quiz 147, 273-4. Review.

PMID:
15705003
5.
6.

Diet, diabetes and schizophrenia: review and hypothesis.

Peet M.

Br J Psychiatry Suppl. 2004 Apr;47:S102-5. Review.

PMID:
15056602
7.
8.

Mortality in schizophrenia.

Auquier P, Lançon C, Rouillon F, Lader M.

Pharmacoepidemiol Drug Saf. 2007 Dec;16(12):1308-12. Review.

PMID:
17944000
10.

Metabolic comorbidity in schizophrenia.

Jacob R, Chowdhury AN.

Indian J Med Sci. 2008 Jan;62(1):23-31. Review.

PMID:
18239269
12.

Diet and lifestyle influences on risk of coronary heart disease.

Hu FB.

Curr Atheroscler Rep. 2009 Jul;11(4):257-63. Review.

PMID:
19500488
13.

[Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].

Vanuzzo D, Pilotto L, Mirolo R, Pirelli S.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):6S-17S. Review. Italian.

PMID:
18773746
14.

Optimal medical treatment of cardiovascular risk factors: can we prevent the development of heart failure?

Alba AC, Delgado DH.

Expert Rev Cardiovasc Ther. 2009 Feb;7(2):147-57. doi: 10.1586/14779072.7.2.147. Review.

PMID:
19210211
16.

Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder.

Laursen TM, Munk-Olsen T, Agerbo E, Gasse C, Mortensen PB.

Arch Gen Psychiatry. 2009 Jul;66(7):713-20. doi: 10.1001/archgenpsychiatry.2009.61.

PMID:
19581562
17.

[Impact of duration and treatment of arterial hypertension on health-related quality of life].

Raskeliene V, Babarskiene MR, Macijauskiene J, Seskevicius A.

Medicina (Kaunas). 2009;45(5):405-11. Lithuanian.

18.

Metabolic syndrome and mental illness.

Newcomer JW.

Am J Manag Care. 2007 Nov;13(7 Suppl):S170-7. Review. Erratum in: Am J Manag Care. 2008 Feb;14(2):76.

19.

Coronary heart disease and cardiovascular risk factors among people aged 25-65 years, as seen in Romanian primary healthcare.

Bunescu DM, Stoffers HE, van den Akker M, Jan Dinant G.

Eur J Gen Pract. 2008;14(2):56-64. doi: 10.1080/13814780802343141.

PMID:
18720274
20.

Prevalence and awareness of cardiovascular risk factors in patients with schizophrenia: a cross-sectional study in a low cardiovascular disease risk geographical area.

Bernardo M, Cañas F, Banegas JR, Casademont J, Riesgo Y, Varela C; RICAVA Study Group.

Eur Psychiatry. 2009 Oct;24(7):431-41. doi: 10.1016/j.eurpsy.2009.07.010. Epub 2009 Sep 26.

PMID:
19783126

Supplemental Content

Support Center